January 18, 2014 / 8:20 AM / 4 years ago

India's Aurobindo to buy some Actavis businesses in Europe

MUMBAI, Jan 18 (Reuters) - Indian drugmaker Aurobindo Pharma Ltd said it agreed to buy Actavis Plc’s commercial operations in seven Western European countries for about 30 million euros ($41 million), in a bid to increase its international footprint.

Aurobindo said the deal would include commercial infrastructure, products and marketing authorizations in the seven countries. The two companies will also enter a long-term commercial and supply deal to support the growth plans of the businesses.

Although the businesses are currently loss-making, Aurobindo expects them to return to profitability, the company said in a statement.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below